ONCO
Onconetix, Inc.
NASDAQ · USHealthcareBiotechnology
$0.75-1.99%
Price as of Jul 20, 2026
ONCO earnings
Onconetix, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 17, 2026in NaN days
EPS est $-4505.00 · Revenue est $21877
Track record
Beat EPS in 1 of 2 quarters
Avg surprise -11.8% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | — | $-6.71 | — | $21457 | — |
| Mar 12, 2026 | — | $6.05 | — | $303596 | — |
| Nov 13, 2025 | — | $-6.25 | — | $303651 | — |
| Aug 14, 2025 | — | $-4.05 | — | $106494 | — |
| Jun 12, 2025 | — | $21.19 | — | $101630 | — |
| Dec 9, 2024 | — | $-2.24 | — | $406859 | — |
| Aug 29, 2024 | — | $-9.20 | — | $704848 | — |
| May 20, 2024 | $-8.40 | $-6.40 | +23.8% | $700433 | +1107.6% |
| Mar 9, 2024 | — | $-1.00 | — | $58465 | — |
| Nov 17, 2023 | $-0.19 | $-0.28 | -47.4% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-17.